RGNX (REGENXBIO Corp) Yalpi foyda bo'yicha rentabellik

Regenxbio (RGNX) kompaniyasining rasmiy ramzlari

Proprietary viral vektor ishlanmalari REGENXBIO Inc. (RGNX) kompaniyasining operatsion barqarorligini ta'minlaydi, buni GURU.Markets terminalidagi yalpi foyda marginining tarixi tasdiqlaydi, u yerda 77.80 ushbu ko'rsatkichning joriy qiymatini belgilaydi. Daromadlar Zolgensma litsenziyalari va royalti to'lovlariga asoslangan, kuchli biotexnologik obro' esa institutsional ishonchni kafolatlaydi. Kompaniyaga tegishli strategiya miya va ko'zlar uchun innovatsion davolash usullarini tijoratlashtirishga tayanadi.

RGNX regenxbio.com Yalpi rentabellik (04.07.2022 - 20.11.2026)

REGENXBIO (RGNX) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- kotirovkalar va tahlilchilar prognozi:
Kompaniyaning jamlanma tahlili:REGENXBIO
regenxbio.com original mahsuloti

REGENXBIO Inc. (RGNX) uchun bazaviy yalpi marja NAV platformasining monetizatsiya samaradorligini aks ettiradi va bevosita ishlab chiqarish xarajatlari chegirib tashlanganidan keyingi foyda ulushini ko'rsatadi. Ushbu ko'rsatkich operatsion rentabellikni o'lchaydi, bunda gen terapiyasi ishlab chiqarish xarajatlariga bo'lgan yuqori sezgirlik litsenziyalash royalti to'lovlarining barqaror oqimi bilan muvozanatlashgan bo'lib, bu kompaniyaning fundamental baholashida patent ustunligining barqarorligini tasdiqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|solidbio.com (SLDB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning yalpi rentabelligi|Benitec Biopharma - Yalpi foyda bo'yicha rentabellik|DSGN: Sotuvning yalpi rentabelligi|RCKT: Yalpi foyda bo'yicha rentabellik|FDMT - Yalpi marja|LXEO: Yalpi marja|Korro Bio Inc. - Yalpi foyda normasi|EDIT (editasmedicine.com) - Yalpi marja|Yalpi rentabellik SLN|Yalpi rentabellik ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning yalpi rentabelligi|Yalpi rentabellik Sangamo SGMO|NAUT: Sotuvning yalpi rentabelligi|MGX: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Precision BioSciences|GBIO (generationbio.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Yalpi marja|Sotuvning yalpi rentabelligi IMNN (Imunon, Inc.)|Yalpi marja PHIO|MBIO - Yalpi foyda marjasi|Yalpi marja RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Yalpi foyda marjasi|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik